Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 137.18B | 137.18B | 130.04B | 122.75B | 137.65B | 136.01B |
Gross Profit | 39.72B | 37.91B | 37.20B | 35.16B | 36.77B | 35.87B |
EBITDA | 7.88B | 7.98B | 6.99B | 4.17B | 7.49B | 5.00B |
Net Income | 4.13B | 4.13B | 3.58B | 1.61B | 3.90B | 1.55B |
Balance Sheet | ||||||
Total Assets | 57.70B | 57.70B | 52.18B | 47.34B | 48.69B | 47.21B |
Cash, Cash Equivalents and Short-Term Investments | 13.46B | 13.46B | 12.69B | 9.04B | 11.58B | 10.62B |
Total Debt | 12.75B | 12.75B | 11.80B | 11.64B | 12.19B | 13.42B |
Total Liabilities | 30.84B | 30.84B | 28.91B | 27.28B | 29.14B | 30.95B |
Stockholders Equity | 26.86B | 26.86B | 23.27B | 20.06B | 19.54B | 16.26B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.55B | 3.63B | -557.00M | 2.86B | 4.75B |
Operating Cash Flow | 0.00 | 5.27B | 7.36B | 3.33B | 6.13B | 6.80B |
Investing Cash Flow | 0.00 | -3.05B | -3.29B | -4.20B | -3.27B | -1.19B |
Financing Cash Flow | 0.00 | -1.45B | -423.00M | -1.68B | -1.90B | -702.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥31.33B | 7.44 | 2.21% | 5.58% | 10.61% | ||
82 Outperform | ¥20.38B | 6.86 | 4.00% | 8.07% | -13.57% | ||
74 Outperform | ¥18.32B | 12.98 | 2.20% | 3.00% | 6.93% | ||
71 Outperform | ¥38.19B | 8.47 | 4.08% | -0.64% | 17.19% | ||
63 Neutral | $20.50B | 14.76 | -2.72% | 3.09% | 1.90% | -4.74% | |
61 Neutral | ¥28.65B | 38.28 | 3.11% | -2.56% | -46.20% | ||
― | ¥24.49B | 11.09 | 2.20% | ― | ― |